Related Experiment Video

Updated: Aug 26, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

Specific inhibition of gene expression and transactivation functions of hepatitis B virus X protein and c-myc by

Le Hung1, Vijay Kumar

  • 1Virology Group, International Centre for Genetic Engineering and Biotechnology, P.O. Box 10504, Aruna Asaf Ali Marg, New Delhi 110067, India.

FEBS Letters
|February 28, 2004
PubMed

Insights

Hepatocellular carcinoma (HCC) therapy may be advanced by targeting hepatitis B virus X protein (HBx) and c-myc. Small hairpin RNAs (shRNAs) effectively inhibited HBx and c-myc expression and function in cell culture.

Area of Science:

  • Hepatocellular Carcinoma (HCC) Research
  • Molecular Biology
  • Gene Regulation

Background:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Co-expression of c-myc and hepatitis B virus X protein (HBx) is linked to HCC development.
  • Targeting oncogenic pathways is crucial for effective HCC therapies.

Purpose of the Study:

  • To investigate the potential of small interfering RNA (siRNA) and small hairpin RNA (shRNA) in regulating HBx and c-myc.
  • To assess the efficacy of shRNAs targeting HBx and c-myc in inhibiting their expression and transactivation.
  • To explore the feasibility of siRNA-based therapeutic strategies for HCC.

Main Methods:

  • Construction of expression vectors for shRNAs targeting distinct regions of HBx and c-myc.
  • Investigation of shRNA regulatory effects in COS-1 cell culture.
  • Assessment of dose-dependent inhibition of gene expression and transactivation functions.

Main Results:

  • Individual shRNAs demonstrated dose-dependent, specific inhibition of HBx and c-myc expression.
  • Recombinantly expressed shRNAs effectively blocked the transactivation functions of HBx and c-myc.
  • Cumulative inhibitory effects were observed when using two different shRNAs, despite varying efficiencies.

Conclusions:

  • shRNAs targeting HBx and c-myc show significant potential for regulating these oncogenes.
  • The cumulative inhibitory effects suggest a promising strategy for HCC treatment.
  • siRNA-based therapies represent a viable avenue for future HCC therapeutic development.

More Related Videos

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...